Subscribe to RSS

DOI: 10.1055/s-0045-1813677
Primary Large Cell Neuroendocrine Carcinoma of the Prostate Gland: An Uncommon Case
Authors
Abstract
Primary large cell neuroendocrine prostate cancer is a rare and aggressive cancer commonly observed as a transformation of an already known prostate adenocarcinoma and on long-term androgen deprivation, although it can arise de novo. It has high potential for distant metastatic spread and is generally associated with poor survival compared to the classical adenocarcinoma type of prostate cancer. We present a case of an 83-year-old who had orchidectomy for treatment of metastatic prostate adenocarcinoma with normalization of prostate-specific antigen levels and subsequently developed recurrence with large cell neuroendocrine transformation.
Authors' Contributions
All authors contributed to the content, design, literature search, article preparation and writing, article editing, and article review. The article has been approved by all the authors. Each author believes that the article represents honest work.
Publication History
Article published online:
18 December 2025
© 2025. The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution License, permitting unrestricted use, distribution, and reproduction so long as the original work is properly cited. (https://creativecommons.org/licenses/by/4.0/)
Thieme Medical and Scientific Publishers Pvt. Ltd.
A-12, 2nd Floor, Sector 2, Noida-201301 UP, India
-
References
- 1 Taher A, Jensen CT, Yedururi S. et al. Imaging of neuroendocrine prostatic carcinoma. Cancers (Basel) 2021; 13 (22) 5765
- 2 Parimi V, Goyal R, Poropatich K, Yang XJ. Neuroendocrine differentiation of prostate cancer: a review. Am J Clin Exp Urol 2014; 2 (04) 273-285
- 3 Guo H, Ci X, Ahmed M. et al. ONECUT2 is a driver of neuroendocrine prostate cancer. Nat Commun 2019; 10 (01) 278
- 4 Okoye E, Choi EK, Divatia M, Miles BJ, Ayala AG, Ro JY. De novo large cell neuroendocrine carcinoma of the prostate gland with pelvic lymph node metastasis: a case report with review of literature. Int J Clin Exp Pathol 2014; 7 (12) 9061-9066
- 5 Nguyen N, Franz II RD, Mohammed O. et al. A systematic review of primary large cell neuroendocrine carcinoma of the prostate. Front Oncol 2024; 14: 1341794
- 6 Moch H, Cubilla AL, Humphrey PA, Reuter VE, Ulbright TM. The 2016 WHO classification of tumours of the urinary system and male genital organs—part A: renal, penile, and testicular tumours. Eur Urol 2016; 70 (01) 93-105
- 7 Evans AJ, Humphrey PA, Belani J, van der Kwast TH, Srigley JR. Large cell neuroendocrine carcinoma of prostate: a clinicopathologic summary of 7 cases of a rare manifestation of advanced prostate cancer. Am J Surg Pathol 2006; 30 (06) 684-693
- 8 Tu X, Chang T, Nie L. et al. Large cell neuroendocrine carcinoma of the prostate: a systematic review and pooled analysis. Urol Int 2019; 103 (04) 383-390
- 9 Sanli Y, Garg I, Kandathil A. et al. Neuroendocrine tumor diagnosis and management: 68Ga-DOTATATE PET/CT. AJR Am J Roentgenol 2018; 211 (02) 267-277

